Clinical and Experimental Hypertension Part A Theory and Practice · 1988 · 16 citations · 13 references
PharmacyPharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacodynamicsBlood Pressure ManagementDiuretic TherapyHypertension ManagementHypertension PharmacotherapyAntihypertensive Drug TherapyAntihypertensive PharmacologyAntihypertensive TreatmentBlood PressureCalcium Channel ModulatorsHypertensive Drug ResponseRandomized Crossover Designs
Seven hypertensive patients receiving the dihydropyridine calcium channel blocking agent nicardipine were given placebo, 6.25, 12.5, 25 and 50 mg hydrochlorothiazide (HCTZ) in a randomized crossover design. Blood pressure (BP) decreased by about 7/3 mmHg irregardless of dose. In contrast, potassium, glucose and uric acid increased in a dose-dependent fashion. The hypokalemic and hyperglycemic responses at 50 mg were larger than usually seen with HCTZ. Low doses of HCTZ provided a modest antihypertensive effect, but 25 and 50 mg of HCTZ were no more effective in lowering BP and gave unusually large metabolic side effects when combined with a calcium channel blocker.
13
Friedrich C. Luft, George R. Aronoff, Rebecca Sloan et al. · Hypertension · 1985 · 68 citations · Full text
S. H. Taylor, Bernard Silke, Rajeev Ahuja et al. · Journal of Cardiovascular Pharmacology · 1982 · 51 citations